Treatment with mycophenolate mofetil is associated with a modest therapeutic benefit in some patients with demyelinating polyneuropathy

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1457, 2004-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycophenolate mofetil monitoring of substantial clinical benefit

By  

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Mycophenolate Mofetil for the Treatment of Systemic Sclerosis

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 2, 2008-03 ,pp. : 134-136

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic Inflammatory Demyelinating Polyneuropathy Possibly Associated with Tacrolimus

By Haviv Y.S.   Friedlaender M.   Dranitzki-Elhallel M.  

Clinical Drug Investigation, Vol. 18, Iss. 2, 1999-08 ,pp. : 169-172

Adis International

Access to resources Recommend Favorite

Ciclosporin/mycophenolate mofetil/prednisolone: Kidney disorders associated with human polyomavirus in renal transplant patients: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1190, 2008-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

The Use of Mycophenolate Mofetil for the Treatment of Systemic Sclerosis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 1, 2008-03 ,pp. : 11-14

Bentham Science Publishers

Access to resources Recommend Favorite